Eduardo J Martinez

This inventor holds 22 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Rgenix, Inc., Inspirna, Inc., Euclises Pharmaceuticals, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eduardo J Martinez. Retrieved from https://idiyas.com/inventor/eduardo-j-martinez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 12)

% Patents Active = 90.9

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 32(Granted Patents)

Company Filing History:

Euclises Pharmaceuticals, Inc.

patents

4. 3 out of 3

Haro Pharmaceuticals Inc.

Universitéde Montreal

patents

7. 2 out of 4,626

California Institute of Technology

Sea Pharmaceuticals LLC

patent

10. 1 out of 1

Tansna Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Chromene Compounds

Ascaroside Derivatives

Metal Salts

Pharmaceutical Compositions

Bi-Polycyclic Compounds

Creatine Transport Inhibitors

LXR Agonists

Guanidine-Coxib Agents

Stability Formulations

Nitrooxy-Chromene Conjugates

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12544356 - Combination of a chromene compound and a second active agent (2026-02-10),

2. 12473323 - Ascaroside derivatives and methods of use (2025-11-18),

3. 12258303 - Metal salts and uses thereof (2025-03-25),

4. 11878956 - Metal salts and uses thereof (2024-01-23),

5. 11845770 - Ascaroside derivatives and methods of use (2023-12-19),

6. 11685726 - Pharmaceutical compositions of 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid and ester derivatives thereof (2023-06-27),

7. 11629118 - Formulations with improved stability (2023-04-18),

8. 11459292 - Metal salts and uses thereof (2022-10-04),

9. 11174220 - Metal salts and uses thereof (2021-11-16),

10. 10954194 - 18-20 member bi-polycyclic compounds (2021-03-23),

11. 10752591 - 18-20 member bi-polycyclic compounds (2020-08-25),

12. 10717704 - Inhibitors of creatine transport and uses thereof (2020-07-21),

13. 10669296 - LXR agonists and uses thereof (2020-06-02),

14. 10512623 - Pharmaceutically acceptable salts of B-Guanidinopropionic acid with improved properties and uses thereof (2019-12-24),

15. 10377715 - 18-20 member bi-polycyclic compounds (2019-08-13),

Title: Unveiling the Inventive Journey of Eduardo J Martinez

Introduction:

Eduardo J Martinez, hailing from Bryn Mawr, PA, is a prolific inventor who has made remarkable contributions to the field of pharmaceuticals and healthcare. With an impressive portfolio of 19 patents, Martinez stands as a beacon of innovation in the industry.

Latest Patents:

Martinez's recent patents include groundbreaking inventions such as 'Metal salts and uses thereof,' which focus on enhancing the physical properties and stability of certain metal salts for pharmaceutical compositions. Additionally, his invention 'Ascaroside derivatives and methods of use' showcases his commitment to developing novel treatments for immune disorders and inflammation.

Career Highlights:

Throughout his career, Martinez has left an indelible mark on the industry with his innovative solutions. He has notably worked with reputable companies such as Rgenix, Inc. and Inspirna, Inc., where he continued to push the boundaries of scientific exploration.

Collaborations:

In his quest for innovation, Martinez has collaborated with esteemed professionals in the field, including the likes of John Jeffrey Talley and Andreas G Grill. Together, they have synergized their expertise to spearhead cutting-edge research initiatives and pave the way for transformative advancements in healthcare.

Conclusion:

Eduardo J Martinez's inventive prowess and unwavering dedication to scientific discovery have positioned him as a trailblazer in the realm of pharmaceutical innovation. His groundbreaking patents and collaborative efforts underscore his profound impact on the industry, making him a driving force behind the evolution of modern healthcare practices.

Profile summary based on public USPTO records.